Stay updated with breaking news from Director Program Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Via Satellite announced today that SpiderOak, the leader in zero-trust cybersecurity solutions for next generation space systems, has been...
OXEIA BIOPHARMACEUTICALS ANNOUNCES NEW BOARD AND MANAGEMENT TEAM MEMBERS AND RELOCATES CORPORATE HEADQUARTERS TO BOSTON - read this article along with other careers information, tips and advice on BioSpace
Intravacc announces positive preclinical data for its SARS- CoV-2 nose spray vaccine Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2 Intranasal vaccine administration has significant advantages over injectables OMV technology is a powerful vaccine platform for future pandemics Bilthoven, The Netherlands, 7 April 2021 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has obtained positive preclinical results for its SARS-CoV-2 Outer Membrane Vesicle (OMV) based recombinant Spik...
Share this article Share this article BILTHOVEN, Netherlands, April 7, 2021 /PRNewswire/ -- Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has obtained positive preclinical results for its SARS-CoV-2 Outer Membrane Vesicle (OMV) based recombinant Spike protein (rSp) candidate nose spray vaccine. For the preclinical study four groups of mice and four groups of hamsters received two intranasal immunizations on day one and day 21. One group of mice and hamsters received a vaccine based on OMV's mixed with rSp (CovOM...